NVCT - Nuvectis Pharma Inc
Nuvectis Pharma Inc Logo

NVCT - Nuvectis Pharma Inc

https://www.nuvectis.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.

52W High
$11.80
52W Low
$4.44
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.28
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-7.38
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
10.08
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
43.55%
Institutions (25–75% balanced)
13.90%
Shares Outstanding
25,456,800
Float
14,536,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.16
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.50%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.1787
Previous
-0.2127
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025